Spirapril (hydrochloride)
Spirapril (SCH 33844) hydrochloride is a potent angiotensin converting enzyme (ACE) inhibitor with antihypertensive activity. Spirapril competitively binds to ACE and prevents the conversion of angiotensin I to angiotensin II. Spirapril is an orally active proagent of Spiraprilat and can be used for the research of hypertension, congestive heart failure[1].
Product Specifications
CAS Number
94841-17-5
Product Name Alternative
SCH 33844 (hydrochloride)
UNSPSC
12352005
Hazard Statement
H302, H312, H332
Target
Angiotensin-converting Enzyme (ACE)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/spirapril-hydrochloride.html
Purity
99.2
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C([C@H](C1)N(C([C@@H](N[C@H](C(OCC)=O)CCC2=CC=CC=C2)C)=O)CC31SCCS3)O.[H]Cl
Molecular Formula
C22H31ClN2O5S2
Molecular Weight
503.07
Precautions
H302, H312, H332
References & Citations
[1]Spirapril. Drugbank.|[2]B Maul, et al. Alcohol consumption is controlled by angiotensin II. FASEB J
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
Launched
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Trefoil Factor 2, Recombinant, Human (TFF2, SML1, Spasmolysin, Spasmolytic Polypeptide, SP)
Trefoil Factor 2, Recombinant, Human (TFF2, SML1, Spasmolysin, Spasmolytic Polypeptide, SP)
Anti-SARS CoV2 Spike RBD Antibody (Clone: ABM2A3.1D12)